Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
The Journal of Experimental Medicine
|
June 1, 1972
Classification of thymus-derived and marrow-derived lymphocytes by demonstration of their antigen-binding characteristics
J S Haskill, B E Elliott, R Kerbel, et al.
Cancer Research
|
December 15, 1988
Expression of epithelial-like markers and class I major histocompatibility antigens by a murine carcinoma growing in the mammary gland and in metastases: orthotopic site effects
B E Elliott, L Maxwell, M Arnold, et al.
Journal of Cellular Biochemistry
|
June 22, 2000
Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met)
A B Tuck, B E Elliott, C Hota, et al.
Journal of Cellular Physiology. Supplement
|
January 1, 1984
Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment
R S Kerbel, P Frost, R Liteplo, et al.
Cancer Research
|
September 15, 1987
In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma
B E Elliott, D A Carlow, L Ivimey, et al.
International Journal of Cancer
|
November 15, 1984
Adoptive immune therapy in mice bearing poorly immunogenic metastases, using T lymphocytes stimulated in vitro against highly immunogenic mutant sublines
J W Dennis, S Laferté, M S Man, et al.
Immunogenetics
|
January 1, 1980
Antigen-binding receptors on T cells from long-term MLR. evidence of binding sites for allogeneic and self-MHC products
B E Elliott, Z A Nagy, B J Takacs, et al.
Genes, Chromosomes & Cancer
|
June 1, 1992
Karyotypic evolution of a murine mammary adenocarcinoma in vitro and during progression from primary to metastatic growth in vivo
B E Elliott, W Xu, K Mudrik, et al.
Scandinavian Journal of Immunology
|
June 1, 1991
Capacity of CD8+ T cells to reject immunogenic variants of a spontaneous murine carcinoma: lack of non-specific (NK1.1+) effector mechanisms
B E Elliott, A Barron, L Maxwell, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
July 26, 2000
Specific inhibition of growth factor-stimulated extracellular signal-regulated kinase 1 and 2 activation in intact cells by electroporation of a growth factor receptor-binding protein 2-Src homology 2 binding peptide
L Raptis, H L Brownell, A M Vultur, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
The Journal of Experimental Medicine
|
June 1, 1972
Classification of thymus-derived and marrow-derived lymphocytes by demonstration of their antigen-binding characteristics
J S Haskill, B E Elliott, R Kerbel, et al.
Cancer Research
|
December 15, 1988
Expression of epithelial-like markers and class I major histocompatibility antigens by a murine carcinoma growing in the mammary gland and in metastases: orthotopic site effects
B E Elliott, L Maxwell, M Arnold, et al.
Journal of Cellular Biochemistry
|
June 22, 2000
Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met)
A B Tuck, B E Elliott, C Hota, et al.
Journal of Cellular Physiology. Supplement
|
January 1, 1984
Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment
R S Kerbel, P Frost, R Liteplo, et al.
Cancer Research
|
September 15, 1987
In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma
B E Elliott, D A Carlow, L Ivimey, et al.
International Journal of Cancer
|
November 15, 1984
Adoptive immune therapy in mice bearing poorly immunogenic metastases, using T lymphocytes stimulated in vitro against highly immunogenic mutant sublines
J W Dennis, S Laferté, M S Man, et al.
Immunogenetics
|
January 1, 1980
Antigen-binding receptors on T cells from long-term MLR. evidence of binding sites for allogeneic and self-MHC products
B E Elliott, Z A Nagy, B J Takacs, et al.
Genes, Chromosomes & Cancer
|
June 1, 1992
Karyotypic evolution of a murine mammary adenocarcinoma in vitro and during progression from primary to metastatic growth in vivo
B E Elliott, W Xu, K Mudrik, et al.
Scandinavian Journal of Immunology
|
June 1, 1991
Capacity of CD8+ T cells to reject immunogenic variants of a spontaneous murine carcinoma: lack of non-specific (NK1.1+) effector mechanisms
B E Elliott, A Barron, L Maxwell, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
July 26, 2000
Specific inhibition of growth factor-stimulated extracellular signal-regulated kinase 1 and 2 activation in intact cells by electroporation of a growth factor receptor-binding protein 2-Src homology 2 binding peptide
L Raptis, H L Brownell, A M Vultur, et al.
Page
of 6